|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shi J, Qu YP and Hou P: Pathogenetic
mechanisms in gastric cancer. World J Gastroenterol.
20:13804–13819. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watanabe H, Jass JR and Sobin LH:
Histological Classification of Gastric Tumours. In: Histological
typing of oesophageal and gastric tumors. World Health
Organization. International Histological Classification of Tumours.
Springer. (Berlin, Heidelberg). 1990.
|
|
5
|
Hohenberger P and Gretschel S: Gastric
cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alberts SR, Cervantes A and van de Velde
CJ: Gastric cancer: Epidemiology, pathology and treatment. Ann
Oncol. 14 (Suppl 2):ii31–ii36. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu H, Rusiecki JA, Zhu K, Potter J and
Devesa SS: Stomach carcinoma incidence patterns in the United
States by histologic type and anatomic site. Cancer Epidemiol
Biomarkers Prev. 18:1945–1952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Henson DE, Dittus C, Younes M, Nguyen H
and Albores-Saavedra J: Differential trends in the intestinal and
diffuse types of gastric carcinoma in the United States, 1973–2000:
Increase in the signet ring cell type. Arch Pathol Lab Med.
128:765–770. 2004.PubMed/NCBI
|
|
9
|
Jézéquel J, Bessaguet C, Verveur C, Faycal
J, Richert Z, Metges JP, Volant A, Nousbaum JB and Robaszkiewicz M:
Trends in incidence, management, and survival of gastric and cardia
carcinomas in the area of Finistere (France) between 1984 and 2003.
Eur J Gastroenterol Hepatol. 22:1412–1419. 2010.PubMed/NCBI
|
|
10
|
Ha TK, An JY, Youn HK, Noh JH, Sohn TS and
Kim S: Indication for endoscopic mucosal resection in early signet
ring cell gastric cancer. Ann Surg Oncol. 15:508–513. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim JP, Kim SC and Yang HK: Prognostic
significance of signet ring cell carcinoma of the stomach. Surg
Oncol. 3:221–227. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hyung WJ, Noh SH, Lee JH, Huh JJ, Lah KH,
Choi SH and Min JS: Early gastric carcinoma with signet ring cell
histology. Cancer. 94:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Taghavi S, Jayarajan SN, Davey A and
Willis AI: Prognostic significance of signet ring gastric cancer. J
Clin Oncol. 30:3493–3498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gronnier C, Messager M, Robb WB, Thiebot
T, Louis D, Luc G, Piessen G and Mariette C; FREGAT working
group-FRENCH, : Is the negative prognostic impact of signet ring
cell histology maintained in early gastric adenocarcinoma? Surgery.
154:1093–1099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pernot S, Voron T, Perkins G,
Lagorce-Pages C, Berger A and Taieb J: Signet-ring cell carcinoma
of the stomach: Impact on prognosis and specific therapeutic
challenge. World J Gastroenterol. 21:11428–11438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ,
Kim SK and Lee JH: Clinicopathological characteristics of signet
ring cell carcinoma of the stomach. ANZ J Surg. 74:1060–1064. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Kim S, Lai JF, Hyung WJ, Choi WH,
Choi SH and Noh SH: Advanced gastric carcinoma with signet ring
cell histology. Oncology. 72:64–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Voron T, Messager M, Duhamel A, Lefevre J,
Mabrut JY, Goere D, Meunier B, Brigand C, Hamy A, Glehen O, et al:
Is signet-ring cell carcinoma a specific entity among gastric
cancers? Gastric Cancer. 19:1027–1040. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uemura N, Okamoto S, Yamamoto S, Matsumura
N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ:
Helicobacter pylori infection and the development of gastric
cancer. N Engl J Med. 345:784–789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith BR and Stabile BE: Extreme
aggressiveness and lethality of gastric adenocarcinoma in the very
young. Arch Surg. 144:506–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Messager M, Lefevre JH, Pichot-Delahaye V,
Souadka A, Piessen G, Mariette C, Arnaud JP, Balon JM, Bonnetain F,
Borie F, et al FREGAT working group - FRENCH, : The impact of
perioperative chemotherapy on survival in patients with gastric
signet ring cell adenocarcinoma: A multicenter comparative study.
Ann Surg. 254:684–693. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Inoue K, Nakane Y, Kogire M, Fujitani K,
Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, et al:
Phase II trial of preoperative S-1 plus cisplatin followed by
surgery for initially unresectable locally advanced gastric cancer.
Eur J Surg Oncol. 38:143–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bass AJ, Thorsson V, Shmulevich I,
Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C,
Shen H, et al Cancer Genome Atlas Research Network, : Comprehensive
molecular characterization of gastric adenocarcinoma. Nature.
513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guilford P, Hopkins J, Harraway J, McLeod
M, McLeod N, Harawira P, Taite H, Scoular R, Miller A and Reeve AE:
E-cadherin germline mutations in familial gastric cancer. Nature.
392:402–405. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lei Z, Tan IB, Das K, Deng N, Zouridis H,
Pattison S, Chua C, Feng Z, Guan YK, Ooi CH, et al: Identification
of molecular subtypes of gastric cancer with different responses to
PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology.
145:554–565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakazawa K, Yashiro M and Hirakawa K:
Keratinocyte growth factor produced by gastric fibroblasts
specifically stimulates proliferation of cancer cells from
scirrhous gastric carcinoma. Cancer Res. 63:8848–8852.
2003.PubMed/NCBI
|
|
27
|
Washington K: 7th edition of the AJCC
cancer staging manual: stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shu P, Qin J, Shen K, Chen W, Liu F, Fang
Y, Wang X, Wang H, Shen Z, Sun Y, et al: The IGCA staging system is
more accurate than AJCC7 system in stratifying survival of patients
with gastric cancer in stage III. BMC Cancer. 17:2382017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ji X, Bu ZD, Yan Y, Li ZY, Wu AW, Zhang
LH, Zhang J, Wu XJ, Zong XL, Li SX, et al: The 8th edition of the
American Joint Committee on Cancer tumor-node-metastasis staging
system for gastric cancer is superior to the 7th edition: results
from a Chinese mono-institutional study of 1663 patients. Gastric
Cancer. 21:643–652. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bièche I, Onody P, Laurendeau I, Olivi M,
Vidaud D, Lidereau R and Vidaud M: Real-time reverse
transcription-PCR assay for future management of ERBB2-based
clinical applications. Clin Chem. 45:1148–1156. 1999.PubMed/NCBI
|
|
32
|
Bieche I, Parfait B, Le Doussal V, Olivi
M, Rio MC, Lidereau R and Vidaud M: Identification of CGA as a
novel estrogen receptor-responsive gene in breast cancer: An
outstanding candidate marker to predict the response to endocrine
therapy. Cancer Res. 61:1652–1658. 2001.PubMed/NCBI
|
|
33
|
Ohta H, Aoyagi K, Fukaya M, Danjoh I, Ohta
A, Isohata N, Saeki N, Taniguchi H, Sakamoto H, Shimoda T, et al:
Cross talk between hedgehog and epithelial-mesenchymal transition
pathways in gastric pit cells and in diffuse-type gastric cancers.
Br J Cancer. 100:389–398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanabe S, Aoyagi K, Yokozaki H and Sasaki
H: Gene expression signatures for identifying diffuse-type gastric
cancer associated with epithelial-mesenchymal transition. Int J
Oncol. 44:1955–1970. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Phrakonkham P, Brouland JP, Saad HS,
Bergès R, Pimpie C, Pocard M, Canivenc-Lavier MC and
Perrot-Applanat M: Dietary exposure in utero and during lactation
to a mixture of genistein and an anti-androgen fungicide in a rat
mammary carcinogenesis model. Reprod Toxicol. 54:101–109. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vacher S, Castagnet P, Chemlali W,
Lallemand F, Meseure D, Pocard M, Bieche I and Perrot-Applanat M:
High AHR expression in breast tumors correlates with expression of
genes from several signaling pathways namely inflammation and
endogenous tryptophan metabolism. PLoS One. 13:e01906192018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Thomassen I, van Gestel YR, van Ramshorst
B, Luyer MD, Bosscha K, Nienhuijs SW, Lemmens VE and de Hingh IH:
Peritoneal carcinomatosis of gastric origin: A population-based
study on incidence, survival and risk factors. Int J Cancer.
134:622–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Humar B, Blair V, Charlton A, More H,
Martin I and Guilford P: E-cadherin deficiency initiates gastric
signet-ring cell carcinoma in mice and man. Cancer Res.
69:2050–2056. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen H, Lu W, Huang C, Ding K, Xia D, Wu Y
and Cai M: Prognostic significance of ZEB1 and ZEB2 in digestive
cancers: A cohort-based analysis and secondary analysis.
Oncotarget. 8:31435–31448. 2017.PubMed/NCBI
|
|
43
|
Wu Y, Grabsch H, Ivanova T, Tan IB, Murray
J, Ooi CH, Wright AI, West NP, Hutchins GG, Wu J, et al:
Comprehensive genomic meta-analysis identifies intra-tumoural
stroma as a predictor of survival in patients with gastric cancer.
Gut. 62:1100–1111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Takemura S, Yashiro M, Sunami T, Tendo M
and Hirakawa K: Novel models for human scirrhous gastric carcinoma
in vivo. Cancer Sci. 95:893–900. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Q, Wang P, Shao M, Chen SW, Xu ZF,
Xu F, Yang ZY, Liu BY, Gu QL, Zhang WJ, et al: Clinicopathological
correlation of keratinocyte growth factor and matrix
metalloproteinase-9 expression in human gastric cancer. Tumori.
101:566–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kakiuchi M, Nishizawa T, Ueda H, Gotoh K,
Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, et
al: Recurrent gain-of-function mutations of RHOA in diffuse-type
gastric carcinoma. Nat Genet. 46:583–587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao H, Guo L, Zhao H, Zhao J, Weng H and
Zhao B: CXCR4 over-expression and survival in cancer: A system
review and meta-analysis. Oncotarget. 6:5022–5040. 2015.PubMed/NCBI
|
|
48
|
Izumi D, Ishimoto T, Miyake K, Sugihara H,
Eto K, Sawayama H, Yasuda T, Kiyozumi Y, Kaida T, Kurashige J, et
al: CXCL12/CXCR4 activation by cancer-associated fibroblasts
promotes integrin β1 clustering and invasiveness in gastric cancer.
Int J Cancer. 138:1207–1219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Qiao J, Liu Z, Yang C, Gu L and Deng D:
SRF promotes gastric cancer metastasis through stromal fibroblasts
in an SDF1-CXCR4-dependent manner. Oncotarget. 7:46088–46099. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiang Z, Zhou ZJ, Xia GK, Zhang XH, Wei
ZW, Zhu JT, Yu J, Chen W, He Y, Schwarz RE, et al: A positive
crosstalk between CXCR4 and CXCR2 promotes gastric cancer
metastasis. Oncogene. 36:5122–5133. 2017. View Article : Google Scholar : PubMed/NCBI
|
